^
    Claudin18.2 IHC 14G11 pharmDx is an immunohistochemistry (IHC) assay for the detection of CLDN18.2 protein in gastric and gastroesophageal junction (GEJ) adenocarcinoma with the potential for other indications.
    Cancer:
    Gastric Cancer, Gastroesophageal Junction Adenocarcinoma
    Gene:
    CLDN18 (Claudin 18)
    Drug:
    osemitamab (TST001)
    Method:
    Immunohistochemistry (IHC)